Internship

Summer 2025 – Computer Aided Drug Design Internship

Confirmed live in the last 24 hours

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Princeton, NJ, USA

Onsite presence is essential for collaboration and productivity.

Category
Bioinformatics
Computational Biology
Biology & Biotech
Required Skills
Python
Java
C/C++
Data Analysis
Requirements
  • An undergraduate student in chemistry, biological sciences, machine learning or a related field with a computational background preferred.
  • Skills in application of computational software packages in any area
  • Ability to independently analyze data using software packages.
  • Basic programming experience in at least one scripting language (e.g., Python) or programming language (Java, C, C++) preferred
  • Excellent communication and organizational skills and ability to work within a multidisciplinary teams
  • Personal attributes of curiosity, integrity, creativity, problem solving, and strong work ethic
Responsibilities
  • Computational project work that may include one or more the following - data analysis and visualization, statistical analysis, molecular modeling and software development and/or scripting.
  • Develop and build computational solutions to tackle drug discovery problems
  • Interact with project teams and collaborate on key issues for analysis and experiments
  • Communicate your analysis and findings to project teams

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs, providing affordable alternatives that maintain the same quality and safety standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while adhering to sustainability and corporate responsibility principles.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.

Help us improve and share your feedback! Did you find this helpful?